Vicore Pharma Holding AB (publ) (VICO.ST)
SEK 7.77
(1.17%)
SEK 7.77
(1.17%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -3.22 SEK | 19.3% |
| 2022 | -3.99 SEK | 6.12% |
| 2021 | -4.25 SEK | -56.83% |
| 2020 | -2.71 SEK | -25.46% |
| 2019 | -2.16 SEK | -127.37% |
| 2018 | -0.95 SEK | -25.0% |
| 2017 | -0.76 SEK | -61.7% |
| 2016 | -0.47 SEK | -46.87% |
| 2015 | -0.32 SEK | -130.19% |
| 2014 | 1.06 SEK | 983.33% |
| 2013 | -0.12 SEK | -30.29% |
| 2012 | -0.09 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.28 SEK | 128.0% |
| 2024 Q2 | -0.50 SEK | -278.57% |
| 2023 Q4 | -1.00 SEK | -72.41% |
| 2023 Q1 | -0.81 SEK | 2.41% |
| 2023 Q2 | -0.85 SEK | -4.94% |
| 2023 FY | - SEK | 19.3% |
| 2023 Q3 | -0.58 SEK | 31.76% |
| 2022 Q1 | -1.30 SEK | -30.0% |
| 2022 Q2 | -0.92 SEK | 29.23% |
| 2022 FY | - SEK | 6.12% |
| 2022 Q3 | -0.95 SEK | -3.26% |
| 2022 Q4 | -0.83 SEK | 12.63% |
| 2021 Q1 | -0.76 SEK | 27.62% |
| 2021 Q4 | -1.00 SEK | 26.47% |
| 2021 Q3 | -1.36 SEK | -38.78% |
| 2021 Q2 | -0.98 SEK | -28.95% |
| 2021 FY | - SEK | -56.83% |
| 2020 FY | - SEK | -25.46% |
| 2020 Q1 | -0.56 SEK | 13.85% |
| 2020 Q3 | -0.65 SEK | -35.42% |
| 2020 Q4 | -1.05 SEK | -61.54% |
| 2020 Q2 | -0.48 SEK | 14.29% |
| 2019 FY | - SEK | -127.37% |
| 2019 Q4 | -0.65 SEK | -20.37% |
| 2019 Q3 | -0.54 SEK | 14.29% |
| 2019 Q2 | -0.63 SEK | -57.5% |
| 2019 Q1 | -0.40 SEK | 59.6% |
| 2018 Q4 | -0.99 SEK | -241.38% |
| 2018 Q3 | -0.29 SEK | -200.0% |
| 2018 Q1 | 0.26 SEK | 172.22% |
| 2018 FY | - SEK | -25.0% |
| 2018 Q2 | 0.29 SEK | 11.54% |
| 2017 FY | - SEK | -61.7% |
| 2017 Q4 | -0.36 SEK | -227.27% |
| 2017 Q3 | -0.11 SEK | 15.38% |
| 2017 Q2 | -0.13 SEK | 7.14% |
| 2017 Q1 | -0.14 SEK | -7.69% |
| 2016 Q1 | -0.14 SEK | -27.27% |
| 2016 FY | - SEK | -46.87% |
| 2016 Q3 | -0.09 SEK | 7.77% |
| 2016 Q2 | -0.10 SEK | 32.0% |
| 2016 Q4 | -0.13 SEK | -48.06% |
| 2015 Q1 | -0.09 SEK | -158.47% |
| 2015 FY | - SEK | -130.19% |
| 2015 Q2 | -0.09 SEK | 2.96% |
| 2015 Q4 | -0.11 SEK | -49.66% |
| 2015 Q3 | -0.07 SEK | 13.63% |
| 2014 Q4 | 0.15 SEK | 617.7% |
| 2014 Q3 | 0.02 SEK | 59.54% |
| 2014 FY | - SEK | 983.33% |
| 2014 Q2 | 0.01 SEK | 0.0% |
| 2014 Q1 | 0.01 SEK | 169.31% |
| 2013 Q1 | - SEK | 100.0% |
| 2013 Q3 | -0.02 SEK | 0.0% |
| 2013 Q4 | -0.02 SEK | 2.07% |
| 2013 FY | - SEK | -30.29% |
| 2013 Q2 | - SEK | 0.0% |
| 2012 Q3 | -0.02 SEK | 0.0% |
| 2012 Q4 | -0.04 SEK | -105.5% |
| 2012 FY | - SEK | 0.0% |